Cargando…

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling

Interferon regulatory factors (IRFs) play roles in various biological processes including cytokine signaling, cell growth regulation and hematopoietic development. Although it has been reported that several IRFs are involved in bone metabolism, the role of IRF2 in bone cells has not been elucidated....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Inyoung, Kim, Jung Ha, Kim, Kabsun, Seong, Semun, Lee, Keun-Bae, Kim, Nacksung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505232/ https://www.ncbi.nlm.nih.gov/pubmed/34488926 http://dx.doi.org/10.5483/BMBRep.2021.54.9.070

Ejemplares similares

Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1
por: Kim, Inyoung, et al.
Publicado: (2017)

NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-κB and Reactive Oxygen Species Pathways
por: Kim, Jung Ha, et al.
Publicado: (2015)

The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation
por: Kim, Inyoung, et al.
Publicado: (2019)

MicroRNA-26a Regulates RANKL-Induced Osteoclast Formation
por: Kim, Kabsun, et al.
Publicado: (2015)

Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway
por: Kim, Kabsun, et al.
Publicado: (2020)

Overexpression of Neurogenin 1 Negatively Regulates Osteoclast and Osteoblast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2022)

The ATF3–OPG Axis Contributes to Bone Formation by Regulating the Differentiation of Osteoclasts, Osteoblasts, and Adipocytes
por: Kim, Jung Ha, et al.
Publicado: (2022)

RCANs regulate the convergent roles of NFATc1 in bone homeostasis
por: Kim, Jung Ha, et al.
Publicado: (2016)

Regulation of NFATc1 in Osteoclast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2014)

Alternative regulatory mechanism for the maintenance of bone homeostasis via STAT5-mediated regulation of the differentiation of BMSCs into adipocytes
por: Seong, Semun, et al.
Publicado: (2021)

STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis
por: Lee, Jongwon, et al.
Publicado: (2016)

Adaptor protein CrkII negatively regulates osteoblast differentiation and function through JNK phosphorylation
por: Kim, Jung Ha, et al.
Publicado: (2019)

Transcription Factor Lmx1b Negatively Regulates Osteoblast Differentiation and Bone Formation
por: Kim, Kabsun, et al.
Publicado: (2022)

Downregulation of Runx2 by 1,25-Dihydroxyvitamin D(3) Induces the Transdifferentiation of Osteoblasts to Adipocytes
por: Kim, Jung Ha, et al.
Publicado: (2016)

Bifunctional Role of CrkL during Bone Remodeling
por: Kim, Jung Ha, et al.
Publicado: (2021)

LIM Homeobox Transcription Factor 1-β Expression is Upregulated in Patients with Osteolysis after Total Ankle Arthroplasty and Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation in Vitro
por: Kim, Kabsun, et al.
Publicado: (2022)

Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
por: Kim, Jeong-Mi, et al.
Publicado: (2017)

Erratum to: Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
por: Kim, Jeong-Mi, et al.
Publicado: (2017)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
por: Wu, Lili, et al.
Publicado: (2019)

Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts
por: Kim, Jung Ha, et al.
Publicado: (2014)

Signaling Pathways in Osteoclast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2016)

NADPH oxidase gp91(phox) contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1
por: Kang, In Soon, et al.
Publicado: (2016)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
por: Kim, Eun-Jung, et al.
Publicado: (2018)

Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
por: Hwang, Youn-Hwan, et al.
Publicado: (2018)

Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1
por: Ibáñez, Lidia, et al.
Publicado: (2022)

Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
por: Kang, Moo Rim, et al.
Publicado: (2014)

Oat Seedlings Extract Inhibits RANKL-Induced c-Fos/NFATc1 Transcription Factors in the Early Stage of Osteoclast Differentiation
por: Yang, Ji Yeong, et al.
Publicado: (2022)

Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis
por: Kim, Ju-Young, et al.
Publicado: (2014)

The Effects of Aronia melanocarpa ‘Viking’ Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling
por: Ghosh, Mithun, et al.
Publicado: (2018)

Anti-Müllerian Hormone Negatively Regulates Osteoclast Differentiation by Suppressing the Receptor Activator of Nuclear Factor-κB Ligand Pathway
por: Kim, Jung Ha, et al.
Publicado: (2021)

Serum amyloid A inhibits RANKL-induced osteoclast formation
por: Oh, Eunseo, et al.
Publicado: (2015)

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023)

Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity
por: Hur, Jeonghwan, et al.
Publicado: (2016)

Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-κB activation
por: Bak, Sun-Uk, et al.
Publicado: (2017)

A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts
por: Kim, Hyun-Ju, et al.
Publicado: (2014)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
por: Kim, Hyung Joon, et al.
Publicado: (2019)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
por: Hong, Guoju, et al.
Publicado: (2017)

Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways
por: Choi, Sik-Won, et al.
Publicado: (2012)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
por: Zhou, Lin, et al.
Publicado: (2015)

Maackiain dampens osteoclastogenesis via attenuating RANKL‐stimulated NF‐κB signalling pathway and NFATc1 activity
por: Liu, Yuhao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_esm86h7ugd214ll77cfb7lpkba